You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR ERYTHROMYCIN LACTOBIONATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ERYTHROMYCIN LACTOBIONATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00034736 ↗ A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 2002-08-01 The purpose of this study is to determine the safety and efficacy of levofloxacin in the treatment of children with community acquired pneumonia.
NCT02605122 ↗ Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia Terminated Biomedical Advanced Research and Development Authority Phase 2/Phase 3 2016-04-01 This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the safety and efficacy of solithromycin in children and adolescents with community-acquired bacterial pneumonia (CABP).
NCT02605122 ↗ Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia Terminated Cempra Inc Phase 2/Phase 3 2016-04-01 This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the safety and efficacy of solithromycin in children and adolescents with community-acquired bacterial pneumonia (CABP).
NCT02605122 ↗ Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia Terminated Melinta Therapeutics, Inc. Phase 2/Phase 3 2016-04-01 This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the safety and efficacy of solithromycin in children and adolescents with community-acquired bacterial pneumonia (CABP).
NCT02633579 ↗ Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways Completed Universitaire Ziekenhuizen Leuven N/A 2012-10-01 In this study, the investigators will evaluate if the food intake associated with the infusion of erythromycin is caused by the phase 3 contractions or by another yet unknown effect of erythromycin. To obtain this the investigators will use atropine, a muscarinic receptor antagonist, to inhibit the formation of contractions induced by a low dose of erythromycin
NCT02755064 ↗ Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus Completed Adil Bharucha Phase 1 2010-06-01 With this study, the investigators hoped to learn if the rate at which food empties from the stomach affects blood sugar values. Using data from this study, we hope to improve our ability to control blood sugars in individuals with type 1 diabetes mellitus.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ERYTHROMYCIN LACTOBIONATE

Condition Name

Condition Name for ERYTHROMYCIN LACTOBIONATE
Intervention Trials
Community-acquired Bacterial Pneumonia 1
Diabetes Mellitus, Type 1 1
Gastric Motility 1
Healthy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ERYTHROMYCIN LACTOBIONATE
Intervention Trials
Pneumonia 2
Pneumonia, Bacterial 1
Diabetes Mellitus, Type 1 1
Diabetes Mellitus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ERYTHROMYCIN LACTOBIONATE

Trials by Country

Trials by Country for ERYTHROMYCIN LACTOBIONATE
Location Trials
United States 15
Spain 3
Philippines 1
Hungary 1
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ERYTHROMYCIN LACTOBIONATE
Location Trials
Minnesota 1
Virginia 1
Texas 1
Tennessee 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ERYTHROMYCIN LACTOBIONATE

Clinical Trial Phase

Clinical Trial Phase for ERYTHROMYCIN LACTOBIONATE
Clinical Trial Phase Trials
Phase 3 1
Phase 2/Phase 3 1
Phase 1 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ERYTHROMYCIN LACTOBIONATE
Clinical Trial Phase Trials
Completed 3
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ERYTHROMYCIN LACTOBIONATE

Sponsor Name

Sponsor Name for ERYTHROMYCIN LACTOBIONATE
Sponsor Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1
Biomedical Advanced Research and Development Authority 1
Cempra Inc 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ERYTHROMYCIN LACTOBIONATE
Sponsor Trials
Industry 3
Other 3
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.